Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02110355 |
| Title | A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Los Angeles | California | 90095 | United States | Details | |
| Research Site | Aurora | Colorado | 80045 | United States | Details | |
| Research Site | Boston | Massachusetts | 02114 | United States | Details | |
| Research Site | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Research Site | Nashville | Tennessee | 37232 | United States | Details | |
| Research Site | North Sydney | New South Wales | 2060 | Australia | Details | |
| Research Site | Melbourne | Victoria | 3000 | Australia | Details |